Zynex ucsf study results demonstrate laser technology benefits in resolving racial bias of current led pulse oximeters

Englewood, colo. , dec. 12, 2024 /prnewswire/ -- zynex, inc. (nasdaq: zyxi) ("zynex", "zms", "we" or the "company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced highlights from a recent study comparing its nico™ laser pulse oximeter to conventional led pulse oximeters for the effects of skin pigmentation on spo2 measurements conducted by the university of california, san francisco (ucsf) hypoxia lab.
ZYXI Ratings Summary
ZYXI Quant Ranking